ATE511647T1 - Gegen gastrin-releasing-peptide-vorläufer gerichteter antikörper - Google Patents

Gegen gastrin-releasing-peptide-vorläufer gerichteter antikörper

Info

Publication number
ATE511647T1
ATE511647T1 AT06731744T AT06731744T ATE511647T1 AT E511647 T1 ATE511647 T1 AT E511647T1 AT 06731744 T AT06731744 T AT 06731744T AT 06731744 T AT06731744 T AT 06731744T AT E511647 T1 ATE511647 T1 AT E511647T1
Authority
AT
Austria
Prior art keywords
amino acid
determination
acid sequence
releasing peptide
acid residue
Prior art date
Application number
AT06731744T
Other languages
English (en)
Inventor
Katsumi Aoyagi
Original Assignee
Advanced Life Science Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37307796&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE511647(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Advanced Life Science Inst Inc filed Critical Advanced Life Science Inst Inc
Application granted granted Critical
Publication of ATE511647T1 publication Critical patent/ATE511647T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57572—Gastrin releasing peptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5758—Gastrin releasing peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT06731744T 2005-04-13 2006-04-13 Gegen gastrin-releasing-peptide-vorläufer gerichteter antikörper ATE511647T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005115782 2005-04-13
JP2006007808 2006-04-13

Publications (1)

Publication Number Publication Date
ATE511647T1 true ATE511647T1 (de) 2011-06-15

Family

ID=37307796

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06731744T ATE511647T1 (de) 2005-04-13 2006-04-13 Gegen gastrin-releasing-peptide-vorläufer gerichteter antikörper

Country Status (9)

Country Link
US (1) US7927814B2 (de)
EP (1) EP1876445B1 (de)
JP (1) JP4950880B2 (de)
KR (1) KR101282811B1 (de)
CN (1) CN101160526B (de)
AT (1) ATE511647T1 (de)
CA (1) CA2604608C (de)
ES (1) ES2364185T3 (de)
WO (1) WO2006117994A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5201822B2 (ja) * 2006-12-11 2013-06-05 アボット・ラボラトリーズ ガストリン放出ペプチド前駆体の免疫学的測定方法
EP2214016B1 (de) * 2007-10-26 2014-09-10 Advanced Life Science Institute, Inc. Gegen progastrin freisetzendes peptid gerichteter antikörper und verwendung davon
CN104089949A (zh) * 2014-06-27 2014-10-08 江苏福隆生物技术有限公司 胃泌素释放肽前体定量测定试剂盒、其制备方法及检测方法
CN105067599A (zh) * 2015-08-05 2015-11-18 南京闻智生物科技有限公司 一种检测胃泌素释放肽前体的化学发光免疫检测试剂盒
US11614448B2 (en) * 2017-03-30 2023-03-28 Ecs-Progastrin Sa Compositions and methods for detecting prostate cancer
CN109239348B (zh) * 2017-07-11 2022-03-08 北京科卫临床诊断试剂有限公司 胃泌素释放肽前体检测试剂盒用抗体及试剂盒
WO2019038671A1 (en) * 2017-08-22 2019-02-28 Onkologix Ltd TUMOR-ASSOCIATED PROLIFERATIVE PEPTIDES AND ANTICANCER IMMUNOGEN THEREFOR FOR THE TREATMENT OF LUNG CANCERS AND OTHER CANCERS
CN108982858B (zh) * 2018-07-05 2021-06-15 陕西师范大学 一种基于单克隆抗体检测人proGRP的双夹心ELISA试剂盒
JP7158008B2 (ja) 2018-09-06 2022-10-21 オークマ株式会社 加工品の回収機構および回収方法
CN111349160B (zh) * 2018-12-24 2021-12-03 东莞市朋志生物科技有限公司 一种抗人胃泌素释放肽前体的重组抗体
CN109870570A (zh) * 2018-12-29 2019-06-11 广东云天抗体生物科技有限公司 一种检测猴il-18的酶联免疫试剂盒
CN109870571A (zh) * 2018-12-29 2019-06-11 广东云天抗体生物科技有限公司 一种检测猴g-csf的酶联免疫试剂盒
CN113583124B (zh) * 2021-06-16 2023-12-15 中国辐射防护研究院 一种抗前胃泌素释放肽单克隆抗体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3148695A1 (de) * 1981-12-09 1983-07-21 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 4,4'-dibenzoylaminodianthrimidcarbazol
JP3210994B2 (ja) 1992-06-12 2001-09-25 株式会社先端生命科学研究所 ヒトガストリン放出ペプチド前駆体に対する抗体及びその使用
EP0811683B1 (de) * 1996-06-03 2008-01-23 Ken Yamaguchi Antikörper gegen den menschlichen gastrinfreisetzenden Peptidvorläufer und deren Verwendung
US6504010B1 (en) * 1999-06-30 2003-01-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2003097666A2 (en) * 2002-05-16 2003-11-27 Euro-Celtique, S.A. Use of gastrin releasing peptide (grp) and its receptor in cancer screening

Also Published As

Publication number Publication date
US7927814B2 (en) 2011-04-19
CA2604608A1 (en) 2006-11-09
ES2364185T3 (es) 2011-08-26
US20080182281A1 (en) 2008-07-31
CN101160526A (zh) 2008-04-09
EP1876445A4 (de) 2009-03-18
JPWO2006117994A1 (ja) 2008-12-18
KR20080003325A (ko) 2008-01-07
EP1876445A1 (de) 2008-01-09
WO2006117994A1 (ja) 2006-11-09
CA2604608C (en) 2013-11-19
CN101160526B (zh) 2013-03-06
KR101282811B1 (ko) 2013-07-05
JP4950880B2 (ja) 2012-06-13
EP1876445B1 (de) 2011-06-01

Similar Documents

Publication Publication Date Title
ATE511647T1 (de) Gegen gastrin-releasing-peptide-vorläufer gerichteter antikörper
WO2011022093A3 (en) Methods and devices for detecting the presence of an analyte in a sample
WO2011014879A3 (en) Assay tools and methods of use
DE602006011756D1 (de) Komplexformierungs- und -trennungsverfahren
WO2010090471A3 (ko) 제1형 당뇨병의 신규한 진단 마커
MX337991B (es) Metodo para detectar cancer.
DE60028361D1 (de) Verfahren und zusammensetzungen zur karzinomdiagnose
WO2007001737A3 (en) Methods and compositions for detecting herpes simplex virus type 2
WO2005031005A3 (en) Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample
MX2009009448A (es) Sensibilidad mejorada de determinacion de perfil de anticuerpos a traves de una colocacion en capas incrementada de anticuerpo reportero.
WO2008089072A3 (en) Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring
EP1806363A4 (de) Verfahren zum nachweis vonhepatitis-b-virus-s-antigen
DK1639130T3 (da) Prober, biblioteker og kits til analyse af blandinger af nukleinsyrer og metoder til opbygning af disse
WO2008108385A1 (ja) 糖化ヘキサペプチドの測定方法
HK1077851A1 (en) Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture T
WO2010000493A3 (en) Inorganic-binding peptides and quality control methods using them
WO2008073146A3 (en) Method and apparatus for pyrolysis-induced cleavage in peptides and proteins
WO2009054091A1 (ja) ガストリン放出ペプチド前駆体に対する抗体及びその使用
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
WO2008148987A3 (fr) Procede de detection de composes gazeux halogenes
WO2009131365A3 (ko) 위암 진단 마커로서의 ｃst1, ｄcc1, ifitm1 또는 ｍelk
WO2006002841A3 (en) Analysis method
ATE360034T1 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
WO2011093606A3 (ko) Pna 기반의 실시간 pcr 클램핑을 이용한 braf 돌연변이 검출 방법 및 키트
DE602005014659D1 (de) Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties